Study Title
A Phase 1 Study of CD19 Specific Chimeric Antigen Receptor T-cell for Therapy of persistent and Relapsed B-cell leukaemia and Lymphoma Post Allogeneic Stem Cell Transplantation (The CARTELL Study)
Protocol ID
CARTELL
Disease (Sub Disease)
Leukaemia
Diagnosis Stage
Relapse/refractory
Sponsor
Western Sydney Local Health District, Westmead Hospital
Links
Trial Status
Temporarily Closed
Study Type
Treatment
Phase
Phase 1
Age Eligibility
no limits
ANZCTR
ACTRN12617001579381
| Study Title | A Phase 1 Study of CD19 Specific Chimeric Antigen Receptor T-cell for Therapy of persistent and Relapsed B-cell leukaemia and Lymphoma Post Allogeneic Stem Cell Transplantation (The CARTELL Study) |
|---|---|
| Protocol ID | CARTELL |
| Disease (Sub Disease) | Leukaemia |
| Diagnosis Stage | Relapse/refractory |
| Sponsor | Western Sydney Local Health District, Westmead Hospital |
| Links | https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373934&isReview=true |
| Trial Status | Temporarily Closed |
| Trial Open Date | 19/11/2017 |
| Study Type | Treatment |
| Phase | Phase 1 |
| Age Eligibility | no limits |
| ANZCTR | ACTRN12617001579381 |